Vitalgen

Shanghai Vitalgen BioPharma Co., Ltd. (Vitalgen), founded in March 2020 and headquartered in Shanghai, China, translates cutting-edge gene delivery and gene editing techniques into clinically effective treatments for patients with unmet medical needs. Vitalgen operates a GMP-compliant commercial production platform built on its proprietary ViCas CRISPR/Cas editing tools, ViLNP lipid nanoparticles, and ViVec AAV capsids, developing gene therapies for hereditary diseases and neurodegenerative disorders across a pipeline that includes Bietti Crystalline Dystrophy (VGR-R01), AADC Deficiency, Parkinson's Disease, Gaucher Disease, and Glutaric Acidemia Type I. Several candidates have entered clinical trials and secured U.S. FDA Orphan Drug Designations and an EMA PRIME designation. Surfaced as a portfolio company of IDG Capital and added to the API Evangelist network. The company publishes a corporate marketing website only and exposes no public API, developer portal, or machine-readable surface.

Vitalgen is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Gene Therapy, Gene Editing, and Biopharmaceutical.

Vitalgen’s developer surface includes engineering blog and 1 more developer resources.

6.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyHealthcareGene TherapyGene EditingBiopharmaceuticalBiotechnologyCRISPR

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 6.1/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/vitalgen: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 2

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: vitalgen
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/vitalgen.png
name: Vitalgen
description: Shanghai Vitalgen BioPharma Co., Ltd. (Vitalgen), founded in March 2020 and headquartered in Shanghai, China,
  translates cutting-edge gene delivery and gene editing techniques into clinically effective treatments for patients with
  unmet medical needs. Vitalgen operates a GMP-compliant commercial production platform built on its proprietary ViCas CRISPR/Cas
  editing tools, ViLNP lipid nanoparticles, and ViVec AAV capsids, developing gene therapies for hereditary diseases and neurodegenerative
  disorders across a pipeline that includes Bietti Crystalline Dystrophy (VGR-R01), AADC Deficiency, Parkinson's Disease,
  Gaucher Disease, and Glutaric Acidemia Type I. Several candidates have entered clinical trials and secured U.S. FDA Orphan
  Drug Designations and an EMA PRIME designation. Surfaced as a portfolio company of IDG Capital and added to the API Evangelist
  network. The company publishes a corporate marketing website only and exposes no public API, developer portal, or machine-readable
  surface.
url: https://raw.githubusercontent.com/api-evangelist/vitalgen/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- idg-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Healthcare
- Gene Therapy
- Gene Editing
- Biopharmaceutical
- Biotechnology
- CRISPR
apis: []
common:
- type: Website
  url: http://www.vitalgen.com/en/
- type: Blog
  url: http://www.vitalgen.com/en/index.php?c=category&id=4
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 0
  pass: local-v1